Gabelli Funds’s Abivax ABVX Stock Holding History

Gabelli Funds’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$830K	Buy	7,450 +2,500	+51%	+$296K	0.01%	940
2025 Q4	$668K	Buy	+4,950	New	+$540K	﹤0.01%	991

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Gabelli Funds's ABVX Position: Q1 2026 in Review

Gabelli Funds increased its Abivax (ABVX) stake by 51% in Q1 2026, buying an estimated $296K and bringing the position to 7,450 shares worth $830K. The position accounts for 0.01% of the portfolio, ranked #940.

Gabelli Funds first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

Gabelli Funds held 7,450 shares of Abivax worth $830K as of Q1 2026.
Gabelli Funds bought 2,500 Abivax shares in Q1 2026, an estimated $296K.
Abivax made up 0.01% of Gabelli Funds's portfolio in Q1 2026, its #940 holding.
Gabelli Funds first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.